Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2023 年第 1 季持倉
持倉截至 2023/3/31，2023/5/15 申報。只含多頭部位，變化是跟 2022 年第 4 季比股數。
- 持股檔數
- 54
- 較 2022 年第 4 季 −3
- 總值
- $23.5 億
- 較 2022 年第 4 季 +$5,780 萬 (+2.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| JAZZJazz Pharmaceuticals plc | SHS USD | 1,200,000 | $1.76 億 | 7.5% | +326,447+37.4% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 6,500,000 | $1.58 億 | 6.7% | −1,378,119−17.5% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 6,147,268 | $1.38 億 | 5.9% | +1,565,268+34.2% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 7,432,717 | $1.15 億 | 4.9% | −2,277,283−23.5% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 6,500,000 | $1.11 億 | 4.7% | +2,235,708+52.4% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 2,834,069 | $1.01 億 | 4.3% | +1,628,296+135.0% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 1,700,000 | $9,206 萬 | 3.9% | +1,700,000 | 新進 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 3,422,057 | $9,103 萬 | 3.9% | +1,689,111+97.5% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 3,000,000 | $8,457 萬 | 3.6% | +3,000,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,100,000 | $7,979 萬 | 3.4% | −9,886−0.3% | 減碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 3,000,000 | $6,945 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 729,000 | $6,628 萬 | 2.8% | +729,000 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,187,415 | $6,400 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 2,646,782 | $6,297 萬 | 2.7% | +2,646,782 | 新進 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 6,350,000 | $6,229 萬 | 2.6% | +4,022,049+172.8% | 加碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 2,819,045 | $5,996 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 26,867,479 | $5,830 萬 | 2.5% | +19,452,786+262.4% | 加碼 | 歷史 |
| BIIBBiogen Inc. | COM | 200,000 | $5,561 萬 | 2.4% | −100,000−33.3% | 減碼 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 1,600,000 | $4,584 萬 | 1.9% | −134,143−7.7% | 減碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 30,000,000 | $4,560 萬 | 1.9% | +3,000,000+11.1% | 加碼 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 3,504,390 | $4,058 萬 | 1.7% | +3,504,390 | 新進 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,278,107 | $3,916 萬 | 1.7% | −378,794−14.3% | 減碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 1,250,000 | $3,828 萬 | 1.6% | +83,527+7.2% | 加碼 | 歷史 |
| EXELExelixis, Inc. | COM | 1,931,874 | $3,750 萬 | 1.6% | +1,931,874 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,230,259 | $3,130 萬 | 1.3% | −540,895−30.5% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 15,000,000 | $2,760 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 1,800,000 | $2,741 萬 | 1.2% | −2,050,000−53.2% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,334,633 | $2,689 萬 | 1.1% | −349,567−13.0% | 減碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 2,727,606 | $2,684 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,997,830 | $2,662 萬 | 1.1% | +731,261+32.3% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 704,533 | $2,626 萬 | 1.1% | +4,533+0.6% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,816,531 | $2,416 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,363,201 | $2,106 萬 | 0.9% | +1,363,201 | 新進 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 3,068,259 | $2,047 萬 | 0.9% | −306,135−9.1% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 2,025,137 | $1,983 萬 | 0.8% | −79,037−3.8% | 減碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 3,250,000 | $1,862 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| QUREuniQure N.V. | SHS | 865,767 | $1,744 萬 | 0.7% | +865,767 | 新進 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,345,073 | $1,705 萬 | 0.7% | +2,345,073 | 新進 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 3,952,000 | $1,605 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 3,585,000 | $1,595 萬 | 0.7% | −1,314,179−26.8% | 減碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 1,708,971 | $1,383 萬 | 0.6% | +1,708,971 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 7,720,688 | $1,282 萬 | 0.5% | −500,500−6.1% | 減碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,951,580 | $1,210 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 571,233 | $1,048 萬 | 0.4% | −733,707−56.2% | 減碼 | 歷史 |
| JNCEJounce Therapeutics, Inc. | COM | 4,259,653 | $788.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,837,818 | $641.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | SPON ADS NEW | 1,166,670 | $626.5 萬 | 0.3% | +1,166,670 | 新進 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 3,234,722 | $488.4 萬 | 0.2% | −3,262,254−50.2% | 減碼 | 歷史 |
| NKTXNkarta, Inc. | COM | 1,354,200 | $480.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $399.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 2,524,242 | $376.1 萬 | 0.2% | +2,524,242 | 新進 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 350,000 | $357.0 萬 | 0.2% | +350,000 | 新進 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,022,892 | $354.9 萬 | 0.2% | +327,047+47.0% | 加碼 | 歷史 |
| NKTRNektar Therapeutics | COM | 1,743,248 | $122.5 萬 | 0.1% | +1,743,248 | 新進 | 歷史 |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2022 年第 4 季之後清倉（17 檔）
2022 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 4 季股數 | 2022 年第 4 季市值 | 2022 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | SPONSORED ADR | 700,000 | $8,549 萬 | 3.7% | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 528,244 | $6,845 萬 | 3.0% | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 500,000 | $5,690 萬 | 2.5% | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 1,704,000 | $3,682 萬 | 1.6% | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 4,000,000 | $2,492 萬 | 1.1% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 189,800 | $1,964 萬 | 0.9% | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,048,829 | $1,919 萬 | 0.8% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 500,000 | $1,273 萬 | 0.6% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 871,493 | $950.8 萬 | 0.4% | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 300,000 | $665.7 萬 | 0.3% | – |
| VKTXViking Therapeutics, Inc. | COM | 610,083 | $573.5 萬 | 0.2% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 768,607 | $559.5 萬 | 0.2% | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 1,833,437 | $238.3 萬 | 0.1% | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 445,572 | $191.6 萬 | 0.1% | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 324,238 | $140.1 萬 | 0.1% | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 3,000,000 | $118.5 萬 | 0.1% | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 1,240,369 | $100.5 萬 | <0.1% | 歷史 |